Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy

Despite the availability of molecularly targeted agents for advanced hepatocellular carcinoma (aHCC), these are limited to compensated cirrhotic patients, and concerns about decreased hepatic functional reserve (HFR) and unknown adverse events, which may affect long-term survival, remain unaddressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriya, Kei, Namisaki, Tadashi, Takaya, Hiroaki, Kaji, Kosuke, Kawaratani, Hideto, Shimozato, Naotaka, Sawada, Yasuhiko, Douhara, Akitoshi, Sato, Shinya, Furukawa, Masanori, Kitagawa, Koh, Akahane, Takemi, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914951/
https://www.ncbi.nlm.nih.gov/pubmed/33562238
http://dx.doi.org/10.3390/jcm10040629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914951/
https://www.ncbi.nlm.nih.gov/pubmed/33562238
http://dx.doi.org/10.3390/jcm10040629

Ejemplares similares